Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 in human sewage in Santa Catalina, Brazil, November 2019

View ORCID ProfileGislaine Fongaro, View ORCID ProfilePatrícia Hermes Stoco, Dóris Sobral Marques Souza, View ORCID ProfileEdmundo Carlos Grisard, View ORCID ProfileMaria Elisa Magri, View ORCID ProfilePaula Rogovski, View ORCID ProfileMarcos André Schörner, View ORCID ProfileFernando Hartmann Barazzetti, View ORCID ProfileAna Paula Christoff, View ORCID ProfileLuiz Felipe Valter de Oliveira, View ORCID ProfileMaria Luiza Bazzo, View ORCID ProfileGlauber Wagner, View ORCID ProfileMarta Hernández, View ORCID ProfileDavid Rodriguez-Lázaro
doi: https://doi.org/10.1101/2020.06.26.20140731
Gislaine Fongaro
1Applied Virology Laboratory, Departament of Microbiology, Imunology and Parasitology, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gislaine Fongaro
  • For correspondence: gislaine.fongaro@ufsc.br drlazaro@ubu.es
Patrícia Hermes Stoco
3Protozoology Laboratory, Departament of Microbiology, Imunology and Parasitology, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrícia Hermes Stoco
Dóris Sobral Marques Souza
1Applied Virology Laboratory, Departament of Microbiology, Imunology and Parasitology, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edmundo Carlos Grisard
3Protozoology Laboratory, Departament of Microbiology, Imunology and Parasitology, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edmundo Carlos Grisard
Maria Elisa Magri
4Sanitary and Environmental Engineering Department, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Elisa Magri
Paula Rogovski
1Applied Virology Laboratory, Departament of Microbiology, Imunology and Parasitology, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paula Rogovski
Marcos André Schörner
5Molecular Biology, Microbiology and Serology Laboratory – LBMMS, University Hospital, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcos André Schörner
Fernando Hartmann Barazzetti
5Molecular Biology, Microbiology and Serology Laboratory – LBMMS, University Hospital, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fernando Hartmann Barazzetti
Ana Paula Christoff
6BiomeHub, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana Paula Christoff
Luiz Felipe Valter de Oliveira
6BiomeHub, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luiz Felipe Valter de Oliveira
Maria Luiza Bazzo
5Molecular Biology, Microbiology and Serology Laboratory – LBMMS, University Hospital, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Luiza Bazzo
Glauber Wagner
7Bioinformatics Laboratory, Departament of Microbiology, Imunology and Parasitology, Federal University of Santa Catarina, Florianópolis-SC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Glauber Wagner
Marta Hernández
8Microbiology Section. Faculty of Sciences. University of Burgos. Burgos, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marta Hernández
David Rodriguez-Lázaro
8Microbiology Section. Faculty of Sciences. University of Burgos. Burgos, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Rodriguez-Lázaro
  • For correspondence: gislaine.fongaro@ufsc.br drlazaro@ubu.es
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We analysed human sewage located in Florianópolis (Santa Catalina, Brazil) from late October until the Brazil lockdown on early March. We detected SARS-CoV-2 in two samples collected independently on 27th November 2019 (5.49±0.02 log genome copies/L). Subsequent samplings were positive until 4th March 2020 (coinciding with the first COVID-19 case reported in Santa Catalina), with a SARS-CoV-2 RNA increase of one log (6.68±0.02 log genome copies/L). Our results show that SARS-CoV-2 has been circulating in Brazil since late November 2019, much earlier than the first reported case in the Americas (21st January 2020, USA).

The first cases of atypical pneumonia related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were described in Wuhan City, Hubei Province (China) on December, 2019 [1]. However, some indirect evidences could suggest that the virus had already been circulating a few months previously [2]. After the first reports, the number of cases increased exponentially around the world, and the WHO declared the status of pandemic on 11th March 2020. As of 24th June, 2020, SARS-CoV-2 has caused more than 9,1 M COVID-19 cases worldwide resulting in more than 473,000 deaths in 216 countries. The first diagnosed COVID-19 case in the Americas was reported on 21st January 2020 in the USA (on 25th February in Brazil) [1]. Since then, almost half of the diagnosed cases (49.4%) and deaths (47.8%) worldwide have been reported in that continent [1].

SARS-CoV-2 is a respiratory virus and the transmission route is mainly through respiratory droplets or contact with contaminated surfaces [3]. However, gastrointestinal and liver manifestations with high and prolonged faecal shedding of up to 108 SARS-CoV-2 genome copies per g of stool have reported [4,5]. Consequently, the faecal-oral transmission of SARS-CoV-2 cannot be ruled out, although its role in COVID-19 epidemiology has not been yet determined [4].

The analysis of human and animal sewage has been successfully applied in monitoring the presence of biological risks [6], including enteric viruses [7]. A similar monitoring strategy has been applied for the detection of SARS-CoV-2 [8-15], demonstrating its value as a non-invasive early-warning tool for monitoring the status and trend of COVID-19 infection [12].

Sampling urban sewage in Florianopolis, Santa Catalina, Brazil

We collected urban sewage samples in Florianopolis, Santa Catalina, Brazil (Figure 1) in 6 independent sampling events since 30th October, 2019 until 4th March, 2020. Raw sewage samples were collected from a separate collection sewage system in central Florianopolis, serving a population of approximately 5,000 inhabitants. The sampling was conducted using a submersible pump inside a well, used for inspection and cleaning of the network. The collection system receives wastewater exclusively, with a linear infiltration rate varying from 0.05 – 1 L / s Km, according to the Brazilian regulation for sanitation projects (ABNT – Associação Brasileira de Normas Técnicas n.9646/1986). In all the sampling events, 200 ml of urban sewage was collected and immediately transferred to the Applied Virology and Environmental Engineering Laboratory of the Federal University of Santa Catarina (Brazil), and stored at -80°C until its use. The concentration of the viral particles was performed using 25 mL of each sample as previously described [16]. Murine Norovirus (MNV-1) was artificially inoculated as sample process control virus to estimate the efficiency of extraction and the final viral load [17]. Viral RNA was extracted from concentrates using the QIAamp® Viral RNA Mini kit (QIAGEN, CA, USA) according to the manufacturer’s instructions, and eluted in 200 µL of RNAse free water. Viral RNA was detected by real-time RT-PCR (RT-qPCR) on a 7500 Real-Time PCR instrument (Applied Biosystems, USA). Sample process control virus, MNV-1, was detected as previously published [18]. SARS-CoV-2 was detected by OneStep qPCR Quantinova kit (QIAGEN, Germany) using oligonucleotides and probe previously published targeting the N1 [19], S and RdRp [20] regions of the SARS-CoV-2 genome. Oligonucleotides and a commercial SARS-CoV-2 RNA (2019-nCoV_N_Positive Control, 2 × 105 genome copies/µL) as positive quantitative control were purchased from IDT (Integrated DNA Technologies, Belgium). Samples were considered as positive when the Cq values were ≤ 38.00. All RT-qPCRs were performed in duplicate in two independent experiments. All the positive samples were confirmed using the Seegene Allplex(tm) 2019-nCoV commercial kit in an independent laboratory (Laboratório de Biologia Molecular, Microbiologia e Sorologia, UFSC University Hospital, Florianopolis, Brazil).

Figure 1:
  • Download figure
  • Open in new tab
Figure 1:

Maps of the sampling location in Florianópolis city, Santa Catarina State, Brazil.

The main physical-chemical features of urban sewages sampled are shown in Table 1. Viral RNA extraction from the sewage samples worked adequately considering the nature of the matrix, showing process efficiency values ranging from 1.6 % to 2.6 %, with an overall value of 2.1% ± 0.2% (M ± ES). Notably, while samples were negative in the first two sampling events (30th October and 6th November, 2019), all samples in subsequent events were positive (since 27th November, 2019 until 4th March, 2020) (Figure 2). The overall load was 5.83 ± 0.12 log SARS-CoV-2 genome copies L-1, ranging from 5.49 ± 0.02 (27th November, 2019) to 6.68 ± 0.02 (4th March, 2020) (Figure 2). Those SARS-CoV-2 RNA loads are similar to those found in studies performed in France [15], Spain [12], and USA [11,14]. Remarkably, SARS-CoV-2 RNA was detected as early as 27th November, 2019, 66 days in advance of the first COVID-19 confirmed case in the Americas (in the USA), 91 days in advance of the first case in Brazil, and 97 days in advance of the first confirmed case in Santa Catalina Region. This demonstrates that SARS-CoV-2 was being shed within the community for several months prior to the first cases being reported by regional, national or Pan-American authorities. Few data are available on retrospective studies of SARS-CoV-2 RNA detection in sewage prior to onset of COVID-19 clinical cases in the region of the study. Randazzo et al. [12] conducted a retrospective study of wastewater process plants in the Murcia Region, Spain, and compared the observed data to declared COVID-19 cases at municipality level: the presence of SARS-CoV-2 RNA in sewage was also earlier than the first reported cases.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Sewage system and physical-chemical characterization

Figure 2:
  • Download figure
  • Open in new tab
Figure 2:

Evolution of the presence of SARS-COV-2 RNA in urban sewage, Florianopolis, Brazil. Red dots represent negative results. Black dots represent log10 SARS-CoV-2 genome copy per litre of urban sewage (M ± ES)

Interestingly, while the SARS-CoV-2 RNA loads were stable until late February (5.49 ± 0.02, 5.82 ± 0.01 and 5.65 ± 0.10 log SARS-CoV-2 genome copies L-1 in 30th November, 2019, 11th December, 2019 and 20th February, 2020, respectively), an increase of approximately 1 log was observed on 4th March 2020 (6.68 ± 0.03 log SARS-CoV-2 genome copies L-1), coinciding with the first COVID-19 case diagnosed in the region. Unfortunately, 10 days after the last sampling, the Federal Brazilian government ordered a national lockdown which impaired the continuation of the sampling and therefore the confirmation of that increasing tendency.

In conclusion, we have confirmed the presence of SARS-CoV-2 in the Americas as early as 27th November, 60 days ahead of the reports of COVID-19 cases in the continent and more than 90 days in the case of Brazil. Therefore, our findings demonstrate that SARS-CoV-2 was circulating unnoticed in the community for some months before pandemic status was declared. Our results also show that the SARS-CoV-2 load remained constant until early March, then rose coinciding with the onset of COVID-19 cases in Santa Catalina region. Consequently, this study demonstrates that monitoring of SARS-CoV-2 in wastewater or urban sewage is an excellent tool for anticipating potential epidemiological outbreaks, and would be highly valuable in helping Public Health authorities to define protection measures.

Data Availability

The data are available upon request

References

  1. 1.↵
    WHO, 2020. Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Last access on 25th June.
  2. 2.↵
    Nsoesie EO, Rader B, Barnoon YL, Goodwin L, Brownstein JS. Analysis of hospital traffic and search engine data in Wuhan China indicates early disease activity in the Fall of 2019. Dash.Harvard.edu: 2020: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42669767
  3. 3.↵
    van Doremale n N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.N Engl J Med. 2020:382(16):1564–1567.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Ding s, Liang TJ. Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal– Oral Transmission? A COVID-19 Virological and Clinical Review. Gastroenterol. 2020: https://doi.org/10.1053/j.gastro.2020.04.052
  5. 5.↵
    Lescure FX, Bouadma L., Nguyen D, Parisey M, Wicky PH, Behillil S, et al. 2020. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect. Dis. 2020: 20(6):697–706.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Choi PM, Tscharke BJ, Donner E, O’Brien JW, Grant SC, Kaserzon SL, Mackie R, O’Malley E, Crosbie ND, Thomas KV, Mueller JF. Wastewater-based epidemiology biomarkers: past, present and future. TraC Trends Anal. Chem. 2018: 105: 453–469
    OpenUrl
  7. 7.↵
    Prevost B, Lucas FS, Goncalves A, Richard F, Moulin L, Wurtzer S. Large scale survey of enteric viruses in river and waste water underlines the health status of the local population. Environ. Int. 2015: 79: 42–50.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Ahmed, W., Angel, N., Edson, J., Bibby, K., Bivins, A., O’Brien, J.W., et al. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci. Total Environ. 2020: 728: 138764.
    OpenUrlCrossRefPubMed
  9. 9.
    La Rosa G, Iaconelli M, Mancini P, Bonanno Ferraro G, Veneri C, Bonadonna L, et al. First detection OF SARS-COV-2 IN untreated wastewaters IN Italy. Sci. Total Environ. 2020: 736: 139652
    OpenUrlCrossRef
  10. 10.
    Medema G, Heijnen L, Elsinga G, Italiaander R, Brouwer A. Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early Stage of the Epidemic in The Netherlands. Environ. Sci. Technol. Lett. 2020: https://doi.org/10.1021/acs.estlett.0c00357
  11. 11.↵
    Nemudryi A, Nemudraia A, Surya K, Wiegand T, Buyukyoruk M, Wilkinson R, et al. Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater. medRxiv 2020: https://doi.org/10.1101/2020.04.15.20066746
  12. 12.↵
    Randazzo W, Truchado P, Cuevas-Ferrando E, Simon P, Allende A, et al. SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area. Water Res. 2020: 181: 115942
    OpenUrlCrossRef
  13. 13.
    Rimoldi SG, Stefani F, Gigantiello A, Polesello S, Comandatore F, Mileto D, et al. 2020. Presence and vitality of SARS-CoV-2 virus in wastewaters and rivers. medRxiv.
  14. 14.↵
    Wu F, Xiao A, Zhang J, Gu X, Lee WL, Kauffman K, et al. SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases. medRxiv. 2020: https://doi.org/10.1101/2020.04.05.20051540
  15. 15.↵
    Wurtzer S, Marechal V, Mouchel JM, Moulin L. Time course quantitative detection of SARS-CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases. medRxiv. 2020: https://doi.org/10.1101/2020.04.12.20062679
  16. 16.↵
    Viancelli A, Garcia LA, Kunz A, Steinmetz R, Esteves PA, Barardi CR. Detection of circoviruses and porcine adenoviruses in water samples collected from swine manure treatment systems. Res Vet Sci. 2012:93(1):538–54
    OpenUrlPubMed
  17. 17.↵
    Diez-Valcarce M, Cook N, Hernández M, Rodríguez-Lázaro D. Analytical application of a sample process control in detection of foodborne viroses. Food Anal. Meth. 2011: 4: 614–618.
    OpenUrl
  18. 18.↵
    Di Bartolo I, Diez-Valcarce M, Vasickova P, Kralik P, Hernandez M, Angeloni G, et al. Hepatitis E virus in pork production chain in Czech Republic, Italy, and Spain, 2010. Emerg. Inf. Dis. 2020: 18: 1282–1289.
    OpenUrl
  19. 19.↵
    CDC. CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel. https://www.fda.gov/media/134922/download.
  20. 20.↵
    Chan JFW, Yuan S, Kok KH, To KKG, Chu H, Yang J, et al. Jasper Fuk-Woo Chan - A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet.. 2020: 395(10223):514–523.
    OpenUrlCrossRefPubMed
Back to top
PreviousNext
Posted June 29, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 in human sewage in Santa Catalina, Brazil, November 2019
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 in human sewage in Santa Catalina, Brazil, November 2019
Gislaine Fongaro, Patrícia Hermes Stoco, Dóris Sobral Marques Souza, Edmundo Carlos Grisard, Maria Elisa Magri, Paula Rogovski, Marcos André Schörner, Fernando Hartmann Barazzetti, Ana Paula Christoff, Luiz Felipe Valter de Oliveira, Maria Luiza Bazzo, Glauber Wagner, Marta Hernández, David Rodriguez-Lázaro
medRxiv 2020.06.26.20140731; doi: https://doi.org/10.1101/2020.06.26.20140731
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
SARS-CoV-2 in human sewage in Santa Catalina, Brazil, November 2019
Gislaine Fongaro, Patrícia Hermes Stoco, Dóris Sobral Marques Souza, Edmundo Carlos Grisard, Maria Elisa Magri, Paula Rogovski, Marcos André Schörner, Fernando Hartmann Barazzetti, Ana Paula Christoff, Luiz Felipe Valter de Oliveira, Maria Luiza Bazzo, Glauber Wagner, Marta Hernández, David Rodriguez-Lázaro
medRxiv 2020.06.26.20140731; doi: https://doi.org/10.1101/2020.06.26.20140731

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (450)
  • Dentistry and Oral Medicine (82)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5247)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (755)
  • Geriatric Medicine (80)
  • Health Economics (212)
  • Health Informatics (696)
  • Health Policy (356)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5848)
  • Intensive Care and Critical Care Medicine (358)
  • Medical Education (103)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (762)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (476)
  • Ophthalmology (150)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (140)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (859)
  • Public and Global Health (2004)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (283)
  • Rheumatology (94)
  • Sexual and Reproductive Health (73)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)